A new market study, titled “Global Crohn’s Disease Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.
CROHN’S DISEASE MARKET
Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by inflammation of the digestive or gastrointestinal tract.
CD most commonly occurs at the end of the small intestine.
@Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3792283-global-crohn-s-disease-market-2018-2025
CROHN’S DISEASE MARKET GROWTH:
Global Crohn’s disease (CD) market is estimated to reach USD 13.4 billion by 2026.
The market is driven by increasing cases of Crohn’s disease attributed to rapid industrialization as well as unhealthy lifestyle including fast food consumption and smoking habits.
Also, growing awareness about the health condition and increasing demand for biologics to cure bowel disorders will further drive the market.
However, lack of early diagnosis, the high cost of treatment and patent expiry of blockbuster anti-TNF based drugs may restrain market growth.
Global Crohn’s disease market report segments the market by type, drug class and by region.
Based on the part of the GI tract affected, the market is segmented into Ileocolitis, Ileitis, Gastroduodenal Crohn’s disease, Jejunoileitis, and Crohn’s colitis.
Ileocolitis is the most common type of Crohn’s disease and affects the small intestine, also known as ileum and colon.
Based on the drug type, the market is categorized into anti-diarrheal, anti-inflammatory drugs, immunosuppressors, antibiotics, biologics and pain relievers.
Anti-inflammatory drugs segment is expected to exhibit the highest growth over the forecast period.
Geographically, the market is segmented into five major regions, namely North America, South America, Europe, Asia Pacific, and RoW.
North America is the largest market for Crohn’s disease powered by the growth in the US and Canada.
Several studies have shown that Crohn’s disease is becoming more common in children and adults in the US. Approximately 780,000 people in the US have Crohn’s disease.
MARKET FORECAST, BY APPLICATION
Gastroduodenal Crohn’s disease
By Drug Class
By Distribution Channel
Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
North America (The USA, Canada, Mexico)
South America (Brazil, Argentina, Rest of South America)
Rest of the World
REASONS FOR PURCHASING THE REPORT?
Visualize the composition of Crohn’s disease market across each indication, regarding type and treatment options, highlighting the critical commercial assets and players.
Identify commercial opportunities in Crohn’s disease market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the market – level 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for critical products of all major market players
WHO CAN BENEFIT FROM THIS REPORT?
Equipment Suppliers/ Buyers
Service Providers/ Buyers
Industry Investors/Investment Bankers
Education & Research Institutes
@Enquiry Before Buying https://www.wiseguyreports.com/enquiry/3792283-global-crohn-s-disease-market-2018-2025
Major Key Points of Global Crohn’s Disease Market
- METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Scope of the Report
2.1 Key Trends & Developments
- MARKET OUTLOOK
3.1 Market Drivers
- COMPANY PROFILES
Boehringer Ingelheim GmbH
Eli Lilly and Co.
Janssen Biotech, Inc.
Johnson & Johnson
Novartis International AG
Takeda Pharmaceutical Company Limited
8.2 List of Tables
8.3 Expert Panel Validation
8.5 Contact Us
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)